Brea, California, July 27, 2015 – PharMedQuest, provider of ARC™, announced today the appointment of Anthony P. Lam, M.D., M.H.S., to the position of Medical Director for ARC™. In this role, Dr. Lam will be part of the PharMedQuest and ARC™ management team and will manage the ARC™ clinical team, and lead clinical programs and quality care initiatives.
Dr. Lam received both his B.A. in Natural Sciences/Public Health and his M.H.S. in Epidemiology from the Johns Hopkins University. He then received his Medical Degree from the Albert Einstein College of Medicine, where he stayed for his Internal Medicine residency. Dr. Lam then completed his sub-specialty training in Hematology and Medical Oncology at the Stanford University School of Medicine. Dr. Lam was previously a Clinical Instructor at the Memorial Sloan Kettering Cancer Center in New York, and more recently, a Clinical Instructor within the Urologic Oncology group at the Stanford Cancer Center. He has been involved in clinical trials for prostate, bladder, kidney and testicular cancers and his work has been published and presented at both the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO) annual meetings. In addition to his clinical expertise in hematology/oncology, Dr. Lam has extensive experience in population-based research. He has collaboratively built and managed numerous clinical databases focusing on patient outcomes. At ARC™, he will continue applying both his clinical and research expertise to ensure patients receive high-quality, cost-effective and evidence-based treatments.
In addition to his role as Medical Director for ARC™, Dr. Lam maintains an active oncology practice where he specializes in the treatment of urologic cancers.
ARC™ has been working for delegated payers and served to manage over 1 million covered lives in all lines of businesses including Medicare, Medicaid, and commercial lives. These experiences has allowed ARC™ to build innovative measurements to assess clinical care management, bundled services pricing methodologies, prospective forecasting to assist with medical claim IBNR issues, and much more.
PharMedQuest is a national leader in providing proven cost-effective solutions to some of the most challenging issues in healthcare. We are dedicated to providing transparent and innovative drug management solutions that optimize the clinical, operational and financial complexities of medical specialty drug management for cancer and other complex and rare diseases.
With over 20 years of Experience, PharMedQuest delivers Insight and Value to its Clients through its services, which include holistic Medical Benefit drug management, real-time access to integrated drug utilization and financial metrics and intelligence, comprehensive 340B management, and many other integrated Pharmacy and Medical solutions that go beyond traditional PBM, Specialty Pharmacy, or Utilization Management tools. For more information about PharMedQuest services, call (714) 364-4008 or visit www.PharMedQuest.com.